MELLARIL IN THE TREATMENT OF CHRONICALLY DISTURBED PATIENTS : WITH SPECIAL REFERENCE TO REDUCED EXTRAPYRAMIDAL COMPLICATIONS
Abstract
Moderate to marked improvement in psychomotor behavior was obtained with Mellaril in 17 of the 22 cases in this series. In addition, there was complete elimination of extrapyramidal activity in 15 of 18 patients who had manifested Parkinsonian symptoms with the drugs previously employed. Our observations indicate that Mellaril is equally effective, or more so, than other phenothiazines in the treatment of various psychiatric disorders, but has a distinctly lessened tendency to induce extrapyramidal stimulation. In our experience, this is a significant contribution to the more effective management of larger numbers of disturbed patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
